ESPR icon

Esperion Therapeutics

165 hedge funds and large institutions have $1.6B invested in Esperion Therapeutics in 2017 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 49 increasing their positions, 51 reducing their positions, and 28 closing their positions.

Holders
165
Holders Change
+15
Holders Change %
+10%
% of All Funds
3.75%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.18%
New
44
Increased
49
Reduced
51
Closed
28
Calls
$51.9M
Puts
$49.2M
Net Calls
+$2.65M
Net Calls Change
+$22.4M
Name Market Value Shares Shares
Change
Shares
Change %
TI
176
Trexquant Investment
Connecticut
-16,591 Closed
Renaissance Technologies
177
Renaissance Technologies
New York
-14,500 Closed
OAM
178
Oxford Asset Management
United Kingdom
-14,309 Closed
DTL
179
Dynamic Technology Lab
Singapore
-14,110 Closed
FRM
180
Fox Run Management
Connecticut
-12,700 Closed
VF
181
Virtu Financial
New York
-12,458 Closed
BCM
182
Bayesian Capital Management
New York
-11,127 Closed
LCM
183
Laurion Capital Management
New York
-10,800 Closed
First Trust Advisors
184
First Trust Advisors
Illinois
-9,205 Closed
GCP
185
GSA Capital Partners
United Kingdom
-9,050 Closed
BCM
186
BlueCrest Capital Management
Jersey
-5,099 Closed
Simplex Trading
187
Simplex Trading
Illinois
-3,943 Closed
BA
188
Bristlecone Advisors
Washington
-500 Closed
EPM
189
Equitec Proprietary Markets
Illinois
-400 Closed
SJIM
190
St. Johns Investment Management
Florida
-260 Closed
KF
191
Krilogy Financial
Missouri
-200 Closed
AFNAS
192
American Financial Network Advisory Services
California
-71 Closed
NFG
193
Next Financial Group
Texas
-61 Closed
Nomura Asset Management
194
Nomura Asset Management
Japan
BFM
195
Boothbay Fund Management
New York
ID
196
Integral Derivatives
New York